MP
PKBO

Mangrove Partners’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Mangrove Partners’s Portfolio PKBO Stock Details PKBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-126,844
Closed -$1.23M – 414
2021
Q2 		$1.23M Hold
126,844
– – 0.13% 219
2021
Q1 		$1.22M Buy
+126,844
New +$1.23M 0.12% 173

Other funds holding PKBO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mangrove Partners's PKBO Position: Q3 2021 in Review

Mangrove Partners sold out of Peak Bio, Inc. Common Stock (PKBO) in Q3 2021, closing a stake of 126,844 shares — an estimated $1.23M sold.

Mangrove Partners first reported a position in PKBO in Q1 2021 and held it in 2 quarters. The position peaked at $1.23M in Q2 2021. 30 funds tracked by Wall St. Rank hold PKBO as of Q3 2021.

  • Mangrove Partners reported no remaining Peak Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Mangrove Partners sold 126,844 Peak Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.23M.
  • Mangrove Partners first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Mangrove Partners's Peak Bio, Inc. Common Stock position peaked at $1.23M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q3 2021.

Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.